Article
Daiichi Sankyo takes oncology shift into next phase with new global business unit
Rating:
0.0
Views:
62
Likes:
1
Library:
1
Daiichi Sankyo is taking another big step in its transformation to oncology drugmaker. The pharma company recently laid out plans to create an integrated oncology business unit, tapping current U.S. business chief Ken Keller to take the reins when it opens its doors on April 1.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value